Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rapidly progressive glomerulonephritis.

L P Erwig1, A J Rees

  • 1Department of Medicine and Therapeutics, University of Aberdeen, UK.

Journal of Nephrology
|February 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Single human B cell-derived monoclonal anti-Candida antibodies enhance phagocytosis and protect against disseminated candidiasis.

Nature communications·2019
Same author

Adhesion of Escherichia coli under flow conditions reveals potential novel effects of FimH mutations.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2016
Same author

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Arthritis and rheumatism·2012
Same author

Contribution of Candida albicans cell wall components to recognition by and escape from murine macrophages.

Infection and immunity·2010
Same author

Accurate method for the measurement of small wedge angles.

Applied optics·2010
Same author

A glass foreign body in the knee joint mistaken for ACL avulsion: an unusual case.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2006
Same journal

Correction to: Abdominal arterial calcification profile in kidney transplant candidates: a comparison between patients with autosomal dominant polycystic kidney disease and those with other causes of kidney failure.

Journal of nephrology·2026
Same journal

Lessons for the Clinical Nephrologist. Not to see the forest for the trees: the diagnostic challenge with valproic acid-induced Fanconi-like proximal tubulopathy.

Journal of nephrology·2026
Same journal

Longitudinal trajectories in multidomain frailty among patients with chronic kidney disease.

Journal of nephrology·2026
Same journal

Correction to: Association between primary care physician-nephrologist collaboration and clinical outcomes in patients with stage 5 chronic kidney disease: a JOINT-KD cohort study.

Journal of nephrology·2026
Same journal

Improving eGFR estimation in diabetic populations: insights from real-world data.

Journal of nephrology·2026
Same journal

Barriers delaying treatment in cases at risk of crush syndrome in major disasters: Kahramanmaraş earthquake experience.

Journal of nephrology·2026
See all related articles

Rapidly progressive glomerulonephritis (RPGN) management has improved significantly, with current renal survival rates reaching 70%. Prompt diagnosis and long-term follow-up are crucial for effective treatment and relapse prevention in RPGN patients.

Area of Science:

  • Nephrology
  • Internal Medicine
  • Glomerular Diseases

Background:

  • Rapidly progressive glomerulonephritis (RPGN) management has seen substantial advancements over three decades.
  • RPGN is now a treatable form of glomerulonephritis with improved patient outcomes.

Purpose of the Study:

  • To highlight the transformation in RPGN management.
  • To emphasize the importance of timely diagnosis and ongoing care for renal survival and relapse prevention.

Main Methods:

  • Review of advancements in RPGN treatment strategies over the past 30 years.
  • Analysis of factors contributing to improved renal survival rates.

Main Results:

  • Overall renal survival in RPGN patients has reached 70%.

Related Experiment Videos

  • RPGN is now considered one of the few effectively treatable forms of glomerulonephritis.

    • Conclusions:

    • Effective RPGN management relies on prompt, accurate diagnosis and appropriate treatment.
    • Long-term follow-up is essential to minimize relapse risk in specific RPGN subtypes.